Randomised controlled trial to determine efficacy and safety of prescribed water intake to prevent the progression of autosomal dominant polycystic kidney disease (PREVENT-ADPKD) [ 2018 - 2021 ]

Research Grant

Researchers: A/Pr Gopala Rangan (Principal investigator) ,  A/Pr Anna Rangan ,  A/Pr Sunil Badve ,  Prof David Harris ,  Prof Margaret Allman-Farinelli
View all 6 related researchers

Brief description Increasing the daily intake of water is well known to reduce the risk of developing kidney stones but there is growing evidence that it may also benefit other kidney diseases, particularly autosomal dominant polycystic kidney disease (ADPKD). This study will determine if adequate hydration can slow the progression of ADPKD, and could provide a relatively simple and cheap treatment for preventing the onset of kidney failure due to this disease.

Funding Amount $AUD 757,205.51

Funding Scheme Project Grants

Notes Standard Project Grant